Intrinsic motivated cervical cancer screening intervention framework

Cervical cancer turned into a reason of extreme mortality even though it is preventable. The expansion rate of cervical cancer is at alarming rate internationally, including both developed (e.g. New Zealand) and developing (e.g. Bangladesh) countries. This study considers survey data collected from Chittagong Medical College Hospital in Bangladesh and other secondary data from open sources. Studies have uncovered that younger women aged from 25 to 34 tend not to react to cervical screening program. Without regular cervical cancer screening, the early changes that could progress to cervical cancer suffering would not be picked up. This study aims to address these concerns by proposing a cervical screening intervention program to encourage women of all age group to participate in the screening program. The intervention could contribute to the health sector by decreasing the cervical cancer mortality rate and associated cost. The preliminary investigation shows that about 96% screening take-up following such intervention program suggesting that a proper intrinsic motivated cervical cancer intervention program is required.

I. Introduction

Cancer is anticipated to be an inexorably imperative reason for morbidity and mortality in the following couple of decades, in all parts of the world [1]. Cervical cancer is the second most common female tumor worldwide [2] which forms in tissues of a cervix i.e. the lower part of a person's uterus [3]. Early pap smear test may prevent mortality but not all women are willing to receive it in the appropriate time interval [4]. Data from the US National Center for health statistics in 2017 reveals that only 69% percent had pap smear tests in last three years. Women below 18 years were not interested in pap smear test [5]. The determined changes in population socioeconomic in the following two decades imply that regardless of the possibility that current worldwide disease rates stay unaltered, the evaluated rate of 12.7 million new cancer cases in 2008 will ascend to 21.4 million by 2030 [6].